{"id":22,"date":"2026-11-22T08:45:07","date_gmt":"2026-11-22T08:45:07","guid":{"rendered":"https:\/\/gop.techdance.site\/?p=22"},"modified":"2026-11-22T08:45:07","modified_gmt":"2026-11-22T08:45:07","slug":"organ-transplant-rejection-treatment-cost-in-the-usa-2027-immunosuppressive-drugs-biopsy-and-hospital-fees","status":"publish","type":"post","link":"https:\/\/gop.techdance.site\/organ-transplant-rejection-treatment-cost-in-the-usa-2027-immunosuppressive-drugs-biopsy-and-hospital-fees\/","title":{"rendered":"Organ Transplant Rejection Treatment Cost in the USA 2027 Immunosuppressive Drugs, Biopsy and Hospital Fees"},"content":{"rendered":"\n<article style=\"background:#ffffff;color:#222222;font-family:Arial,Helvetica,sans-serif;font-size:16px;line-height:1.8;padding:15px;\">\n\n<h2>Introduction<\/h2>\n\n<p>Organ transplant rejection is a serious medical complication that occurs when the recipient&#8217;s immune system attacks a transplanted organ. It may affect patients who have received a kidney, liver, heart, lung, or another transplanted organ. Treatment can involve immunosuppressive medications, diagnostic biopsies, intravenous therapies, hospitalization, and intensive specialist monitoring.<\/p>\n\n<p>Understanding organ transplant rejection treatment costs in the USA in 2027 is important for patients and families comparing anti-rejection medication prices, biopsy expenses, transplant specialist fees, and hospital bills.<\/p>\n\n<p>The overall expense depends on the transplanted organ, rejection severity, treatment response, insurance coverage, and whether hospitalization is required. Mild rejection episodes may be managed through medication adjustments, while severe cases can require intensive therapy or prolonged hospital care.<\/p>\n\n<p>This guide examines estimated American transplant rejection treatment expenses for 2027, including diagnosis, immunosuppressive drugs, biopsy procedures, inpatient treatment, insurance benefits, and long-term financial planning.<\/p>\n\n<h2>What Is Organ Transplant Rejection?<\/h2>\n\n<p>Organ transplant rejection happens when the immune system recognizes the transplanted organ as foreign and attacks its tissues.<\/p>\n\n<p>Transplant recipients normally take immunosuppressive medications to reduce this immune response. However, rejection can still occur despite appropriate treatment.<\/p>\n\n<p>Early detection and timely management are important because untreated rejection can damage the transplanted organ and reduce its function.<\/p>\n\n<p>Rejection does not always mean that a transplant has permanently failed. Many episodes respond to treatment, particularly when identified promptly.<\/p>\n\n<h2>Types of Organ Transplant Rejection<\/h2>\n\n<h3>Hyperacute Rejection<\/h3>\n\n<p>Hyperacute rejection occurs very rapidly, sometimes within minutes or hours after transplantation. It is uncommon because modern transplant programs perform compatibility testing before surgery.<\/p>\n\n<p>This severe reaction may cause immediate graft failure and require emergency intervention.<\/p>\n\n<h3>Acute Rejection<\/h3>\n\n<p>Acute rejection can occur within weeks or months after transplantation, but it may also develop years later.<\/p>\n\n<p>Depending on the organ, acute rejection may involve immune cells, antibodies, or both.<\/p>\n\n<p>Treatment may include corticosteroids, changes in maintenance medications, or specialized therapies.<\/p>\n\n<h3>Chronic Rejection<\/h3>\n\n<p>Chronic rejection generally develops gradually and can cause progressive damage to the transplanted organ.<\/p>\n\n<p>Management depends on the affected organ and may involve medication optimization, treatment of contributing conditions, and long-term monitoring.<\/p>\n\n<p>Advanced chronic graft failure may eventually require consideration of retransplantation in selected patients.<\/p>\n\n<h2>Which Transplanted Organs Can Be Rejected?<\/h2>\n\n<ul>\n<li>Kidney transplants.<\/li>\n<li>Liver transplants.<\/li>\n<li>Heart transplants.<\/li>\n<li>Lung transplants.<\/li>\n<li>Pancreas transplants.<\/li>\n<li>Intestinal transplants.<\/li>\n<\/ul>\n\n<p>Each organ has different rejection patterns, monitoring requirements, and treatment strategies. Costs therefore vary considerably across transplant programs.<\/p>\n\n<h2>Common Signs of Transplant Rejection<\/h2>\n\n<p>Symptoms depend on the affected organ. Some rejection episodes cause few or no noticeable symptoms and are detected through routine testing.<\/p>\n\n<ul>\n<li>Unexplained fever or fatigue.<\/li>\n<li>Reduced urine output after kidney transplantation.<\/li>\n<li>Rising creatinine or abnormal kidney function tests.<\/li>\n<li>Abnormal liver enzymes after liver transplantation.<\/li>\n<li>Shortness of breath after heart or lung transplantation.<\/li>\n<li>Unexpected swelling or fluid retention.<\/li>\n<li>Changes in blood pressure.<\/li>\n<li>Reduced exercise tolerance or worsening organ function.<\/li>\n<\/ul>\n\n<p>These findings can also indicate infection or other complications. Transplant recipients should contact their transplant team promptly when concerning symptoms or abnormal test results occur.<\/p>\n\n<h2>How Is Organ Transplant Rejection Diagnosed?<\/h2>\n\n<h3>Blood Tests<\/h3>\n\n<p>Blood tests assess organ function, medication concentrations, and possible complications.<\/p>\n\n<p>Kidney recipients may undergo creatinine testing, while liver recipients require liver function assessments.<\/p>\n\n<h3>Donor-Specific Antibody Testing<\/h3>\n\n<p>Specialized laboratory testing may identify antibodies directed against donor tissue.<\/p>\n\n<p>These results help clinicians evaluate certain forms of antibody-mediated rejection.<\/p>\n\n<h3>Organ Biopsy<\/h3>\n\n<p>A biopsy removes a small tissue sample from the transplanted organ for microscopic examination.<\/p>\n\n<p>Biopsy findings can help distinguish rejection from infection, medication toxicity, and other causes of organ dysfunction.<\/p>\n\n<h3>Ultrasound and Other Imaging<\/h3>\n\n<p>Ultrasound, CT, MRI, or specialized cardiac and pulmonary testing may be used to evaluate organ function and possible complications.<\/p>\n\n<h2>Treatment Options for Organ Transplant Rejection<\/h2>\n\n<h3>Corticosteroid Therapy<\/h3>\n\n<p>High-dose corticosteroids are commonly used for certain acute cellular rejection episodes.<\/p>\n\n<p>Treatment may involve intravenous methylprednisolone followed by adjustments to oral medication.<\/p>\n\n<h3>Maintenance Immunosuppressive Drugs<\/h3>\n\n<p>Transplant recipients commonly receive medications such as tacrolimus, mycophenolate, corticosteroids, or other agents depending on the transplanted organ.<\/p>\n\n<p>Clinicians may adjust medication doses when rejection occurs.<\/p>\n\n<h3>Antithymocyte Globulin<\/h3>\n\n<p>Antithymocyte globulin may be used for selected severe or steroid-resistant cellular rejection episodes.<\/p>\n\n<p>Because it causes substantial immune suppression, patients require careful monitoring for infections and other complications.<\/p>\n\n<h3>Plasmapheresis<\/h3>\n\n<p>Plasmapheresis, also called plasma exchange, removes antibodies from the bloodstream.<\/p>\n\n<p>It may be used as part of treatment for selected antibody-mediated rejection episodes.<\/p>\n\n<h3>Intravenous Immunoglobulin<\/h3>\n\n<p>Intravenous immunoglobulin, or IVIG, may be administered alongside other treatments for certain antibody-mediated rejection cases.<\/p>\n\n<h3>Other Specialized Therapies<\/h3>\n\n<p>Some patients receive additional immune-targeting medications according to organ-specific protocols and specialist recommendations.<\/p>\n\n<p>Not all therapies have the same evidence base or regulatory approval for transplant rejection, and some uses are off-label.<\/p>\n\n<h2>Organ Transplant Rejection Treatment Cost in the USA in 2027<\/h2>\n\n<p>American transplant rejection expenses vary according to the organ involved, diagnostic requirements, medication selection, hospital resources, and treatment intensity.<\/p>\n\n<p>Reliable nationwide prices for individual rejection episodes are limited because hospitals and insurers use different payment arrangements.<\/p>\n\n<p>The following figures are illustrative 2027 budgeting estimates, not verified national averages or guaranteed quotations.<\/p>\n\n<h3>Estimated USA Cost Breakdown<\/h3>\n\n<table style=\"width:100%;border-collapse:collapse;background:#ffffff;color:#222222;\">\n<tr><th style=\"border:1px solid #dddddd;padding:9px;text-align:left;\">Treatment or Service<\/th><th style=\"border:1px solid #dddddd;padding:9px;text-align:left;\">Estimated Cost (USD)<\/th><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Transplant Specialist Consultation<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$200\u2013$800+<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Blood Tests and Medication Monitoring<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$100\u2013$1,000+ per testing episode<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Donor-Specific Antibody Testing<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$300\u2013$2,000+<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Image-Guided Kidney Transplant Biopsy Episode<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$2,000\u2013$8,000+<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Heart Transplant Biopsy Episode<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$3,000\u2013$12,000+<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Tacrolimus or Other Maintenance Drugs<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$100\u2013$2,000+ per month depending on regimen<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">IV Corticosteroid Treatment Episode<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$1,000\u2013$8,000+ including administration<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Antithymocyte Globulin Treatment Course<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$10,000\u2013$50,000+<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Plasma Exchange Session<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$2,000\u2013$7,000+<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">IVIG Treatment Course<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$5,000\u2013$30,000+<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Hospital Admission for Rejection<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$10,000\u2013$50,000+<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Complex Rejection Hospitalization<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$50,000\u2013$150,000+<\/td><\/tr>\n<\/table>\n\n<p><em>Important: These are hypothetical planning ranges. Hospital admission estimates may already include medication, biopsy, laboratory, and physician charges. Do not add individual items without confirming which services are included.<\/em><\/p>\n\n<h2>USA Transplant Rejection Cost Comparison<\/h2>\n\n<p>Because this article focuses on the United States, the following table compares different American treatment scenarios rather than international countries.<\/p>\n\n<table style=\"width:100%;border-collapse:collapse;background:#ffffff;color:#222222;\">\n<tr><th style=\"border:1px solid #dddddd;padding:9px;text-align:left;\">USA Treatment Scenario<\/th><th style=\"border:1px solid #dddddd;padding:9px;text-align:left;\">Illustrative Overall Budget<\/th><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Outpatient Evaluation and Medication Adjustment<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$500\u2013$5,000+<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Biopsy and Short Treatment Episode<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$5,000\u2013$20,000+<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Inpatient Acute Rejection Treatment<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$10,000\u2013$50,000+<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Complex Antibody-Mediated Rejection Treatment<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$30,000\u2013$100,000+<\/td><\/tr>\n<tr><td style=\"border:1px solid #dddddd;padding:9px;\">Severe Rejection With Intensive Hospital Care<\/td><td style=\"border:1px solid #dddddd;padding:9px;\">$50,000\u2013$150,000+<\/td><\/tr>\n<\/table>\n\n<p>These scenarios are not standardized treatment packages. Actual expenses depend on medical needs, hospital contracts, and insurance arrangements.<\/p>\n\n\n<h2>Immunosuppressive Drug Costs<\/h2>\n\n<p>Immunosuppressive medications are essential for preventing rejection and preserving transplanted organ function. Most solid-organ transplant recipients require long-term treatment, often for life.<\/p>\n\n<p>Common medications include tacrolimus, mycophenolate, prednisone, cyclosporine, and selected other agents. Some patients receive specialized intravenous medications when standard treatment is insufficient.<\/p>\n\n<p>Generic drugs may be less expensive than brand-name alternatives, but the total monthly cost depends on dosage, drug combinations, pharmacy pricing, and insurance benefits.<\/p>\n\n<p>Regular blood testing is also necessary because some medications require careful dose adjustment to maintain effective concentrations while limiting toxicity.<\/p>\n\n<p>Patients should never stop, substitute, or reduce anti-rejection medications without instructions from their transplant team.<\/p>\n\n<h2>Organ Biopsy and Diagnostic Testing Expenses<\/h2>\n\n<p>A biopsy is an important diagnostic procedure when transplant rejection is suspected.<\/p>\n\n<p>Kidney transplant biopsies are commonly performed using ultrasound guidance. Heart transplant recipients may undergo endomyocardial biopsy through a catheter-based procedure.<\/p>\n\n<p>Biopsy-related expenses can include imaging, procedural services, pathology examination, laboratory testing, and observation after the procedure.<\/p>\n\n<p>Additional tests may be required to distinguish rejection from infection, medication toxicity, or other causes of reduced organ function.<\/p>\n\n<h2>Hospital Fees for Transplant Rejection<\/h2>\n\n<p>Hospitalization may be necessary when patients require intravenous medications, plasma exchange, close monitoring, or treatment of serious complications.<\/p>\n\n<p>Common hospital expenses include:<\/p>\n\n<ul>\n<li>Emergency department evaluation.<\/li>\n<li>Inpatient accommodation and nursing care.<\/li>\n<li>Specialist consultations.<\/li>\n<li>Intravenous corticosteroid treatment.<\/li>\n<li>Biopsy and laboratory services.<\/li>\n<li>Plasma exchange or IVIG administration.<\/li>\n<li>Infection screening and treatment.<\/li>\n<li>Intensive care when medically necessary.<\/li>\n<\/ul>\n\n<p>Hospital charges can increase significantly when rejection affects organ function severely or requires several treatment sessions.<\/p>\n\n<h2>Kidney vs Heart, Liver and Lung Rejection Costs<\/h2>\n\n<p>Kidney transplant rejection may involve creatinine monitoring, biopsy, corticosteroids, and treatment for antibody-mediated rejection.<\/p>\n\n<p>Heart transplant rejection may require specialized cardiac imaging, catheter-based biopsy, rhythm monitoring, and hospitalization.<\/p>\n\n<p>Liver transplant rejection often involves liver function testing, medication adjustments, and biopsy when indicated.<\/p>\n\n<p>Lung transplant rejection may require pulmonary function testing, bronchoscopy, imaging, and treatment for respiratory complications.<\/p>\n\n<p>These differences affect the overall cost, but no single organ consistently has the same rejection treatment expense for every patient.<\/p>\n\n<h2>Organ Transplant Rejection Treatment With Health Insurance<\/h2>\n\n<p>Many comprehensive American health insurance plans cover medically necessary transplant rejection treatment, including eligible diagnostic tests, hospital services, and prescribed medications.<\/p>\n\n<p>Coverage depends on the patient&#8217;s specific policy, medical condition, provider network, and authorization requirements.<\/p>\n\n<p>Important insurance considerations include:<\/p>\n\n<ul>\n<li>Annual deductible and out-of-pocket maximum.<\/li>\n<li>Transplant specialist and hospital network participation.<\/li>\n<li>Prescription immunosuppressive drug coverage.<\/li>\n<li>Organ biopsy and pathology benefits.<\/li>\n<li>Coverage for plasma exchange and IVIG.<\/li>\n<li>Prior authorization for specialty therapies.<\/li>\n<li>Hospital admission and intensive care benefits.<\/li>\n<li>Long-term follow-up and laboratory monitoring.<\/li>\n<\/ul>\n\n<p>Insurance approval does not necessarily eliminate personal expenses. Deductibles, copayments, and coinsurance may still apply.<\/p>\n\n<h2>Medicare Coverage for Anti-Rejection Medications<\/h2>\n\n<p>Medicare may cover qualifying immunosuppressive drugs and transplant-related services when applicable requirements are satisfied.<\/p>\n\n<p>For eligible kidney transplant recipients whose Medicare coverage based solely on end-stage renal disease would otherwise end, the Medicare Part B Immunosuppressive Drug benefit may provide continued coverage for qualifying anti-rejection medications.<\/p>\n\n<p>This specialized benefit covers immunosuppressive drugs only. It does not provide comprehensive coverage for hospital admissions, biopsies, or unrelated medical services.<\/p>\n\n<p>Other Medicare beneficiaries may have different transplant medication coverage arrangements depending on their eligibility and circumstances.<\/p>\n\n<h2>Medicaid and Financial Assistance<\/h2>\n\n<p>Medicaid may cover medically necessary transplant rejection treatment for eligible patients, depending on state-specific benefits and requirements.<\/p>\n\n<p>Some hospitals offer financial assistance programs, while transplant social workers may help patients explore medication support and other resources.<\/p>\n\n<p>Patients should review eligibility requirements before assuming that a particular program will pay for treatment.<\/p>\n\n<h2>Organ Transplant Rejection Without Insurance<\/h2>\n\n<p>Uninsured patients may face substantial expenses for biopsies, immunosuppressive medications, hospital admissions, and specialized therapies.<\/p>\n\n<p>Before planned treatment, patients should request written estimates explaining which services are included.<\/p>\n\n<p>Patients should ask whether pathology, laboratory testing, physician services, medications, and follow-up appointments will be billed separately.<\/p>\n\n<h2>Factors Influencing Transplant Rejection Treatment Prices<\/h2>\n\n<h3>1. Type of Transplanted Organ<\/h3>\n\n<p>Kidney, liver, heart, and lung transplants require different diagnostic and treatment approaches.<\/p>\n\n<h3>2. Rejection Severity<\/h3>\n\n<p>Mild rejection may respond to medication adjustments, while severe rejection can require intensive hospital treatment.<\/p>\n\n<h3>3. Medication Selection<\/h3>\n\n<p>Generic maintenance drugs, specialized intravenous therapies, and treatment duration influence expenses.<\/p>\n\n<h3>4. Biopsy and Diagnostic Requirements<\/h3>\n\n<p>Imaging, pathology, antibody testing, and repeated monitoring can increase costs.<\/p>\n\n<h3>5. Hospital and Specialist Fees<\/h3>\n\n<p>Hospitalization length, specialist participation, intensive care, and treatment equipment affect medical spending.<\/p>\n\n<h3>6. Insurance Coverage<\/h3>\n\n<p>Deductibles, negotiated rates, provider networks, and authorization requirements determine much of the patient&#8217;s financial responsibility.<\/p>\n\n<h3>7. Complications and Readmissions<\/h3>\n\n<p>Serious infections, medication toxicity, organ dysfunction, and repeat admissions can substantially increase expenses.<\/p>\n\n<h2>Recovery and Long-Term Monitoring<\/h2>\n\n<p>Recovery depends on the severity of rejection, the affected organ, and response to treatment.<\/p>\n\n<p>Some patients improve after medication adjustments, while others require prolonged treatment and repeated examinations.<\/p>\n\n<p>Long-term monitoring may include blood tests, drug concentration measurements, imaging, and specialist appointments.<\/p>\n\n<p>Patients receiving intensive immunosuppressive treatment may have an increased infection risk and require additional preventive care.<\/p>\n\n<h2>How to Reduce Transplant Rejection Treatment Costs<\/h2>\n\n<ul>\n<li>Verify insurance coverage before planned procedures.<\/li>\n<li>Request complete written hospital estimates.<\/li>\n<li>Confirm transplant specialists are in-network.<\/li>\n<li>Ask about appropriate generic medication options.<\/li>\n<li>Review Medicare and Medicaid eligibility.<\/li>\n<li>Explore prescription assistance programs.<\/li>\n<li>Discuss available hospital financial assistance.<\/li>\n<li>Maintain regular follow-up with the transplant team.<\/li>\n<\/ul>\n\n<p>Preventing avoidable complications through consistent medical care may help reduce unnecessary expenses, although rejection cannot always be prevented.<\/p>\n\n<h2>Frequently Asked Questions<\/h2>\n\n<h3>How much does organ transplant rejection treatment cost in the USA in 2027?<\/h3>\n\n<p>Illustrative costs may range from several hundred dollars for outpatient evaluation to more than $100,000 for severe rejection requiring complex hospitalization.<\/p>\n\n<h3>How much do anti-rejection medications cost?<\/h3>\n\n<p>Monthly expenses vary widely. Generic regimens may cost substantially less than specialized medications, depending on dosage and insurance coverage.<\/p>\n\n<h3>How much does a transplant biopsy cost?<\/h3>\n\n<p>Illustrative biopsy episode costs may range from approximately $2,000 to more than $12,000 depending on the organ, procedure, and facility.<\/p>\n\n<h3>Does insurance cover transplant rejection treatment?<\/h3>\n\n<p>Many comprehensive insurance plans cover medically necessary rejection treatment, subject to policy requirements and patient cost-sharing.<\/p>\n\n<h3>Can transplant rejection be reversed?<\/h3>\n\n<p>Some acute rejection episodes respond successfully to treatment. Chronic rejection can be more difficult to reverse and may cause lasting organ damage.<\/p>\n\n<h3>Are anti-rejection medications required for life?<\/h3>\n\n<p>Most solid-organ transplant recipients need long-term immunosuppressive treatment, often throughout their lives, unless their transplant specialists determine otherwise.<\/p>\n\n<h2>Conclusion<\/h2>\n\n<p>Organ transplant rejection treatment costs in the USA in 2027 depend on immunosuppressive medications, diagnostic biopsies, hospital fees, rejection severity, and insurance coverage.<\/p>\n\n<p>Patients should compare complete treatment estimates, verify medication benefits, and consult experienced transplant specialists before making medical decisions.<\/p>\n\n<p>Early detection, appropriate treatment, consistent medication use, and long-term follow-up can help preserve transplanted organ function and support better financial planning.<\/p>\n\n<p><strong>Medical Disclaimer:<\/strong> This article provides general educational and financial planning information only. It does not replace professional medical advice, diagnosis, or treatment. All 2027 cost ranges are illustrative estimates and should be verified directly with transplant centers, hospitals, pharmacies, and insurance companies.<\/p>\n\n<\/article>\n","protected":false},"excerpt":{"rendered":"<p>Introduction Organ transplant rejection is a serious medical complication that occurs when the recipient&#8217;s immune system attacks a transplanted organ. It may affect patients who have received a kidney, liver, heart, lung, or another transplanted organ. Treatment can involve immunosuppressive medications, diagnostic biopsies, intravenous therapies, hospitalization, and intensive specialist monitoring. Understanding organ transplant rejection treatment [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":23,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-22","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-usa-medical-treatment-costs"],"_links":{"self":[{"href":"https:\/\/gop.techdance.site\/wp-json\/wp\/v2\/posts\/22","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gop.techdance.site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gop.techdance.site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gop.techdance.site\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gop.techdance.site\/wp-json\/wp\/v2\/comments?post=22"}],"version-history":[{"count":1,"href":"https:\/\/gop.techdance.site\/wp-json\/wp\/v2\/posts\/22\/revisions"}],"predecessor-version":[{"id":24,"href":"https:\/\/gop.techdance.site\/wp-json\/wp\/v2\/posts\/22\/revisions\/24"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gop.techdance.site\/wp-json\/wp\/v2\/media\/23"}],"wp:attachment":[{"href":"https:\/\/gop.techdance.site\/wp-json\/wp\/v2\/media?parent=22"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gop.techdance.site\/wp-json\/wp\/v2\/categories?post=22"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gop.techdance.site\/wp-json\/wp\/v2\/tags?post=22"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}